Rockwell Automation Inc. (NYSE:ROK), a leading manufacturing stock, has been highly recommended by hedge funds for investment. On June 26, the company announced that Swiss pharmaceutical firm, Sintetica, has adopted its FactoryTalk PharmaSuite manufacturing execution system (MES).
The integration of this system at Sintetica’s production facility in Switzerland is aimed at improving quality, insights, and external interactions. It is also expected to expedite batch reviews, thereby reducing the time to market for innovative therapies. These therapies include drugs for anesthesia, pain management, intensive care, and neuromodulation.
During the design and implementation phases, consultants from Rockwell Automation worked closely with Sintetica. Following a pilot deployment on two production lines, the feedback from operators has been overwhelmingly positive. They have noted the benefits of data-driven insights in reducing the time spent on monitoring, recording, and disseminating essential batch information and operational machine logs.
Rockwell Automation Inc. (NYSE:ROK) offers industrial automation and digital transformation solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
While the potential of ROK as an investment is recognized, it is believed that certain AI stocks may offer greater upside potential and carry less downside risk. For those seeking an extremely undervalued AI stock that could also significantly benefit from Trump-era tariffs and the onshoring trend, a free report on the best short-term AI stock is available.
In the next few years, it is predicted that 30 stocks should double and 11 hidden AI stocks are recommended for purchase.
Please note that this article was originally published at Insider Monkey.
